HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G R Pettit Selected Research

hydroxyphenstatin

11/2000A pinacol rearrangement/oxidation synthetic route to hydroxyphenstatin.
7/2000Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G R Pettit Research Topics

Disease

20Neoplasms (Cancer)
12/2008 - 01/2000
4Lymphoid Leukemia
11/2000 - 01/2000
2Adenocarcinoma
03/2003 - 10/2001
2Colonic Neoplasms (Colon Cancer)
11/2002 - 01/2000
2Necrosis
03/2002 - 01/2000
2Leukemia
10/2001 - 08/2000
1Carcinoma (Carcinomatosis)
12/2008
1Chronic Kidney Failure (Chronic Renal Failure)
09/2006
1Pre-Eclampsia (Preeclampsia)
09/2006
1Hypertension (High Blood Pressure)
09/2006
1Infections
12/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000
1Alzheimer Disease (Alzheimer's Disease)
01/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2000

Drug/Important Bio-Agent (IBA)

6Phosphates (Orthophosphate)IBA
03/2003 - 01/2000
6TubulinIBA
11/2002 - 01/2000
5fosbretabulin (combretastatin A4)IBA
10/2008 - 01/2000
4ProdrugsIBA
10/2008 - 07/2000
4combretastatin A-1IBA
03/2003 - 07/2000
4SaltsIBA
08/2001 - 06/2000
4Biological ProductsIBA
07/2001 - 01/2000
3Pharmaceutical PreparationsIBA
10/2008 - 07/2000
2soblidotin (TZT 1027)IBA
10/2001 - 07/2000
2hydroxyphenstatinIBA
11/2000 - 07/2000
2Antineoplastic Agents (Antineoplastics)IBA
07/2000 - 07/2000
1Cytochromes c (Cytochrome c)IBA
12/2008
1CaspasesIBA
12/2008
1cephalostatin IIBA
12/2008
1Apoptosomes (Apoptosome)IBA
12/2008
1spongistatin 1IBA
09/2008
1marinobufageninIBA
09/2006
1Adenosine Triphosphatases (ATPase)IBA
09/2006
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
09/2006
1Cisplatin (Platino)FDA LinkGeneric
03/2003
1tempolIBA
04/2002
1Antimitotic AgentsIBA
12/2001
1pancratistatinIBA
12/2001
1Antiparasitic Agents (Antiparasitics)IBA
12/2001
17-deoxynarciclasineIBA
12/2001
1ParaffinIBA
10/2001
1bryostatin 1IBA
10/2001
1BufanolidesIBA
09/2001
1bufadienolideIBA
09/2001
1phakellistatin 11IBA
07/2001
1AcidsIBA
04/2001
1dolastatin 14IBA
04/2001
1DepsipeptidesIBA
04/2001
1tiglic acidIBA
04/2001
1PotassiumIBA
12/2000
1Diphosphates (Pyrophosphates)IBA
12/2000
1SodiumIBA
12/2000
1AzidesIBA
10/2000
1sodium phosphate (trisodium phosphate)FDA LinkGeneric
10/2000
1Proteasome InhibitorsIBA
08/2000
1Protease Inhibitors (Protease Inhibitor)IBA
08/2000
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
08/2000
13-acetoxy-17-prolylaminoandrostaneIBA
08/2000
1Growth InhibitorsIBA
07/2000
1sodium pyrophosphate (disodium pyrophosphate)FDA LinkGeneric
07/2000
1phenstatinIBA
07/2000
1StilbenesIBA
07/2000
1GemcitabineFDA Link
07/2000
1Anti-Bacterial Agents (Antibiotics)IBA
07/2000
1Fluorouracil (Carac)FDA LinkGeneric
01/2000
1Carrier Proteins (Binding Protein)IBA
01/2000
1Peptides (Polypeptides)IBA
01/2000
1Cyclic PeptidesIBA
01/2000
1Phosphotransferases (Kinase)IBA
01/2000
1AntibodiesIBA
01/2000
1SterolsIBA
01/2000
1Vinblastine (Vinblastine Sulfate)FDA Link
01/2000
1hymenialdisineIBA
01/2000
1Glycogen Synthase Kinase 3IBA
01/2000
1dolastatin 10IBA
01/2000

Therapy/Procedure

1Aftercare (After-Treatment)
11/2002
1Therapeutics
10/2001
1Combination Drug Therapy (Combination Chemotherapy)
01/2000